These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
150 related articles for article (PubMed ID: 34595942)
1. Massive retinal infiltrates as the presenting sign of chronic myeloid leukemia: Clinical and imaging features of leukemic retinopathy. Szeto SK; Mohamed S; Tsang CW; Chan CK Eur J Ophthalmol; 2023 Jan; 33(1):NP55-NP63. PubMed ID: 34595942 [TBL] [Abstract][Full Text] [Related]
2. Leukostasis retinopathy with leukemic infiltrates as onset manifestation of chronic myeloid leukemia: a case report. Vicini G; Nicolosi C; Malandrino D; Tozzetti C; Rizzo S; Sodi A Eur J Ophthalmol; 2021 Sep; 31(5):NP116-NP121. PubMed ID: 32476461 [TBL] [Abstract][Full Text] [Related]
3. Chronic myeloid leukemia presenting with bilateral central retinal vein occlusion and massive retinal infiltrates. Goel N; Pangtey B; Thakar M; Raina UK; Ghosh B J AAPOS; 2012 Aug; 16(4):406-8. PubMed ID: 22929456 [TBL] [Abstract][Full Text] [Related]
4. Bilateral Retinal Infiltration and Ischemia as the First Presenting Sign of Chronic Myeloid Leukemia: A Case Report with Multimodal Imaging. Alzuabi AK; Alanazi TA; Alkharashi A; Al-Qahtani KM; Albloushi AF Middle East Afr J Ophthalmol; 2023; 30(2):121-124. PubMed ID: 39006935 [TBL] [Abstract][Full Text] [Related]
5. RETINAL INFILTRATION IN A CASE OF CHRONIC MYELOID LEUKEMIA. Yee C; Scruggs BA; Flaxel CJ Retin Cases Brief Rep; 2023 Nov; 17(6):690-693. PubMed ID: 35385433 [TBL] [Abstract][Full Text] [Related]
6. Leukemic retinopathy and foveal infiltrates. Kumar V; Kumawat D; Dhakal S Int Ophthalmol; 2018 Jun; 38(3):1301-1303. PubMed ID: 28527028 [TBL] [Abstract][Full Text] [Related]
7. [Sudden bilateral decreased vision in a 14-year-old boy]. Marx S; Scheuerle A; Khoramnia R; Tandogan T; Kaiser D; Auffarth GU; Sel S Ophthalmologe; 2017 Aug; 114(8):748-750. PubMed ID: 28138752 [No Abstract] [Full Text] [Related]
8. Unilateral Subhyaloid Hemorrhage as a Presenting Sign of Chronic Myeloid Leukemia. Almater AI; Alhadlaq GS; Alromaih AZ Am J Case Rep; 2022 Apr; 23():e936266. PubMed ID: 35484832 [TBL] [Abstract][Full Text] [Related]
9. Resolution of leukemic retinopathy following treatment with imatinib mesylate for chronic myelogenous leukemia. Christoforidis JB; DeAngelo DJ; D'Amico DJ Am J Ophthalmol; 2003 Mar; 135(3):398-400. PubMed ID: 12614767 [TBL] [Abstract][Full Text] [Related]
10. Bilateral Central Retinal Vein Occlusion as Presenting Feature of Chronic Myeloid Leukemia. Narang S; Gupta P; Sharma A; Sood S; Palta A; Goyal S Middle East Afr J Ophthalmol; 2016; 23(3):253-5. PubMed ID: 27555710 [TBL] [Abstract][Full Text] [Related]
11. BCR-ABL1- positive chronic myeloid leukemia with erythrocytosis presenting as polycythemia vera: a case report. Cornea MI; Levrat E; Pugin P; Betticher DC J Med Case Rep; 2015 Apr; 9():30. PubMed ID: 26187587 [TBL] [Abstract][Full Text] [Related]
12. BCR-ABL Transcript Level as Compared to LDH and Uric Acid Among Chronic Myeloid Leukemic Patients. Hailemariam TS; Mehdi M; Kinde S; Seifu D; Edao A Recent Pat Anticancer Drug Discov; 2021; 16(3):445-455. PubMed ID: 33618649 [TBL] [Abstract][Full Text] [Related]
13. PD166326, a novel tyrosine kinase inhibitor, has greater antileukemic activity than imatinib mesylate in a murine model of chronic myeloid leukemia. Wolff NC; Veach DR; Tong WP; Bornmann WG; Clarkson B; Ilaria RL Blood; 2005 May; 105(10):3995-4003. PubMed ID: 15657179 [TBL] [Abstract][Full Text] [Related]
14. Novel HDAC inhibitor MAKV-8 and imatinib synergistically kill chronic myeloid leukemia cells via inhibition of BCR-ABL/MYC-signaling: effect on imatinib resistance and stem cells. Lernoux M; Schnekenburger M; Losson H; Vermeulen K; Hahn H; Gérard D; Lee JY; Mazumder A; Ahamed M; Christov C; Kim DW; Dicato M; Bormans G; Han BW; Diederich M Clin Epigenetics; 2020 May; 12(1):69. PubMed ID: 32430012 [TBL] [Abstract][Full Text] [Related]
15. Leukostasis retinopathy: An uncommon visual threatening complication of chronic myeloid leukemia with severe hyperleukocytosis - A case report and review of the literature. Chen B; Yan X; Zhang X; Yang H Indian J Ophthalmol; 2018 Dec; 66(12):1871-1874. PubMed ID: 30451209 [TBL] [Abstract][Full Text] [Related]
16. Chronic myeloid leukemia with a rare fusion transcript, e19a2 BCR-ABL1: A report of three cases from India. Sazawal S; Chikkara S; Singh K; Chaubey R; Chandra D; Mishra P; Mahapatra M; Seth T; Saxena R Ann Diagn Pathol; 2017 Apr; 27():24-27. PubMed ID: 28325357 [TBL] [Abstract][Full Text] [Related]
17. ATYPICAL PROLIFERATIVE RETINOPATHY AS THE PRESENTING FEATURE OF CHRONIC MYELOID LEUKEMIA IN A PATIENT WITH DIABETES MELLITUS. Al Falah M; Ballios BG; Yeung SC; Mehraban Far P; Yan P Retin Cases Brief Rep; 2023 Jan; 17(1):61-64. PubMed ID: 33252507 [TBL] [Abstract][Full Text] [Related]
18. Serial monitoring of BCR-ABL transcripts in chronic myelogenous leukemia (CML) treated with imatinib mesylate. Hardling M; Wei Y; Palmqvist L; Swolin B; Stockelberg D; Gustavsson B; Ekeland-Sjöberg K; Wadenvik H; Ricksten A Med Oncol; 2004; 21(4):349-58. PubMed ID: 15579919 [TBL] [Abstract][Full Text] [Related]
19. Priapism as a result of chronic myeloid leukemia: case report, pathology, and review of the literature. Shaeer OK; Shaeer KZ; AbdelRahman IF; El-Haddad MS; Selim OM J Sex Med; 2015 Mar; 12(3):827-34. PubMed ID: 25630365 [TBL] [Abstract][Full Text] [Related]
20. Chronic myeloid leukemia: 2022 update on diagnosis, therapy, and monitoring. Jabbour E; Kantarjian H Am J Hematol; 2022 Sep; 97(9):1236-1256. PubMed ID: 35751859 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]